We're excited to come out of stealth and announce results from our Phase 1a study evaluating MD-18 for the treatment of obesity and diabetes. A step towards bringing transformative medicines to patients in need of better cardiometabolic medicines. https://lnkd.in/gWJCacfH
关于我们
Novel approach targeting the underlying causes of diabetes, obesity and other large, underserved therapeutics areas.
- 网站
-
www.radellapharma.com
Radella Pharmaceuticals LLC的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 私人持股
Radella Pharmaceuticals LLC员工
-
Amir Tirosh
Director, Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center. Professor of Medicine, Tel-Aviv University School of Medicine
-
Joseph Smith, PhD
Head of Structure and Head of Biology - Radella Pharmaceuticals LLC
-
Meghan Hamer
Peptide Chemist at Radella Pharmaceuticals
动态
-
Radella is expanding our computational chemistry expertise. If you are, or know of someone who is, an enthusiastic and committed computational chemist looking to work with a multi-disciplinary team focused on next-generation drugs in heart disease, diabetes and obesity research, we'd love to hear from you. The position is open to remote work. Inquire at info @ radellapharma.com